| |
| |
|
| Insider
Information: |
Gemayel Georges |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
26,236 |
|
|
Indirect Shares
|
5,055 |
|
|
| Direct
Value |
$473,200 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
31,291 |
|
|
| Total
Value |
$473,200 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genzyme Corp |
GENZ |
Executive Vice President |
2007-10-30 |
9,035 |
2007-10-30 |
5,055 |
Premium* |
|
|
Adolor Corp |
ADLR |
Director |
2011-12-07 |
0 |
2007-05-17 |
0 |
Premium* |
|
|
NPS Pharmaceuticals Inc |
NPSP |
Director |
2015-02-21 |
0 |
2014-02-13 |
0 |
Premium* |
|
|
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2020-10-01 |
0 |
|
0 |
Premium* |
|
|
Supernus Pharmaceuticals Inc |
SUPN |
Director |
2024-02-23 |
17,201 |
2020-02-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2020-07-29 |
4 |
OE |
$14.84 |
$148,400 |
D/D |
10,000 |
24,090 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2020-08-05 |
4 |
AS |
$33.00 |
$330,000 |
D/D |
(10,000) |
14,090 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2020-08-05 |
4 |
OE |
$14.84 |
$148,400 |
D/D |
10,000 |
24,090 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2020-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,090) |
0 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2014-02-13 |
4 |
AS |
$37.70 |
$233,288 |
D/D |
(6,188) |
9,000 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,188 |
15,188 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2015-02-21 |
4 |
D |
$46.00 |
$414,000 |
D/D |
(9,000) |
0 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2020-02-21 |
4 |
A |
$23.99 |
$125,012 |
D/D |
5,211 |
5,211 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2022-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,222 |
9,433 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2023-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,882 |
13,315 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Director |
– • – |
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,886 |
17,201 |
0 |
- |
|
36 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
